Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

A Phase Ib Randomized, Observer-Blind, Controlled, Single Center, Dose-Ranging Study of a Group B Streptococcus Vaccine in Healthy Women 18-40 Years of Age

This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine.

Inclusion Criteria:

• Healthy females 18-40 years of age inclusive.

Exclusion Criteria:

• Individuals who are pregnant or nursing.
• Individuals who have had a previous immunization with a vaccine containing streptococcus antigens or any vaccine within 30 days of enrollment through 30 days of study completion.
• Individuals with a history of severe allergic reactions after previous vaccination
• Individuals with designated blood tests that are not within normal range